ROYALTY PHARMA PLC 3.55 percent 02Sep2050 is a Senior Unsecured Note issued by the corporate entity on the 7th of July 2021. The bond matures on the 2nd of September 2050 and carries the semi-annual coupon of 3.550%. ROYALTY is trading at 70.97 as of the 7th of January 2025, a 6.53 percent increase since the beginning of the trading day. The bond's open price was 66.62. ROYALTY has about a 41 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Ratings for ROYALTY PHARMA PLC are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of December 2024 and ending today, the 7th of January 2025. Click here to learn more.
Our tools can tell you how much better you can do entering a position in ROYALTY without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Portfolio Suggestion Now
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
ROYALTY financial ratios help investors to determine whether ROYALTY Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ROYALTY with respect to the benefits of owning ROYALTY security.